Clinical trial

Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol

NCT07255820

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2026-01-01

PhasePHASE4

Study timeline

Study start (actual)2026-01-01Date precision: day

Registry last updated2026-07-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Hypercholesterolemia / Elevated LDL Cholesterolunresolved

Interventions

Rosuvastatin + EzetimibeDRUG

Bempedoic Acid + EzetimibeDRUG

Rosuvastatin + Ezetimibe + Bempedoic AcidDRUG

Sponsors & collaborators

Bahria Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07255820 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.